BrightSpring Health Services (NasdaqGS:BTSG) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsAJ Rice - Managing DirectorCharles Rhyee - Managing DirectorDavid Deuchler - Investor RelationsJared Haase - Equity Research AssociateJen Phipps - CFOJon Rousseau - President and CEOMatthew Gillmor - DirectorWhit Mayo - Senior Managing DirectorConference Call ParticipantsAnn Hynes - Senior Healthcare Services Equity Analyst and Managing DirectorBrian Tanquilut - Senior AnalystDavid Larsen - A ...

BrightSpring Health Services (NasdaqGS:BTSG) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Company ParticipantsAJ Rice - Managing DirectorCharles Rhyee - Managing DirectorDavid Deuchler - Investor RelationsJared Haase - Equity Research AssociateJen Phipps - CFOJon Rousseau - President and CEOMatthew Gillmor - DirectorWhit Mayo - Senior Managing DirectorConference Call ParticipantsAnn Hynes - Senior Healthcare Services Equity Analyst and Managing DirectorBrian Tanquilut - Senior AnalystDavid Larsen - A ...

BrightSpring Health Services (NasdaqGS:BTSG) Q4 2025 Earnings call February 27, 2026 08:30 AM ET Speaker10Day. Thank you for standing by. Welcome to the BrightSpring Health Services, Inc. fourth quarter 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you will need to press star 11 on your telephone. You will then hear an automated message advising you ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K s (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-41938 BrightSpring Health Services, Inc. (Exact name of Registrant as specified in its Charter) | Delaware | 82-2 ...

Fourth Quarter and Full Year 2025 Earnings Presentation costs; and • fluctuations in the amount and frequency of repurchases of our common stock. February 27, 2026 1 Forward-Looking Statements; Non-GAAP Financial Information Forward-Looking Statements This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect our current views with respect to, among other things, our operations and financial per ...

Core Insights - BrightSpring Health Services, Inc. (BTSG) reported quarterly earnings of $0.33 per share, missing the Zacks Consensus Estimate of $0.34 per share, but showing an increase from $0.22 per share a year ago, resulting in an earnings surprise of -1.49% [1] - The company achieved revenues of $3.55 billion for the quarter ended December 2025, exceeding the Zacks Consensus Estimate by 5.85% and up from $3.05 billion year-over-year [2] - BrightSpring Health Services has surpassed consensus EPS estimates three times over the last four quarters and topped revenue estimates four times in the same period [2] Earnings Outlook - The sustainability of the stock's price movement will depend on management's commentary during the earnings call and the company's earnings outlook [3][4] - The current consensus EPS estimate for the upcoming quarter is $0.28 on revenues of $3.31 billion, and for the current fiscal year, it is $1.37 on revenues of $14.56 billion [7] Industry Context - The Medical Services industry, to which BrightSpring belongs, is currently ranked in the bottom 44% of over 250 Zacks industries, indicating potential challenges ahead [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact BrightSpring's stock performance [5][6]

BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance LOUISVILLE, Ky., February 27, 2026 — BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the fourth quarter and full year ended December 31, 2025 and initiated full year 2026 Revenue and Adjusted EBITDA 1 guidance. Fourth ...

LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the fourth quarter and full year ended December 31, 2025 and initiated full year 2026 Revenue and Adjusted EBITDA1 guidance. Fourth Quarter 2025 Financial Highlights(note: all figures represent continuing operations and exclude the Community Living b ...

Key Takeaways BTSG is set to report Q4 2025 results on Feb. 27, with revenues seen at $3.35B and EPS at 34 cents.Pharmacy Solutions likely drove growth on specialty scripts, generics and new drug launches.BTSG may post stronger margins, aided by mix gains, cost control and seasonal strength.BrightSpring Health Services, Inc. (BTSG) is scheduled to release fourth-quarter 2025 results on Feb. 27, before market open. In the last reported quarter, the company’s earnings beat the Zacks Consensus Estimate by 11.1 ...

BrightSpring Health Services, Inc. (NASAQ:BTSG) is among the Most Volatile Stocks. On January 27, 2026, TD Cowen upgraded BrightSpring Health Services, Inc. (NASDAQ:BTSG)’s price objective to $46 from $42 while keeping a Buy rating. The firm noted strong specialty generics trends as a driver of ongoing Q4 momentum. On January 23, 2026, BMO Capital boosted BrightSpring Health Services, Inc. (NASDAQ:BTSG)’s price target from $40 to $46 and maintained its Outperform rating. BMO Capital noted the firm’s com ...